| ||
Ahead of the Bell: Vertex Pharma shares slump Businessweek NEW YORK (AP) — Shares of Vertex Pharmaceuticals Inc. skidded almost 9 percent in premarket trading Friday on safety concerns over one of its experimental hepatitis C drugs. The Cambridge, Mass., company said Thursday that the Food and Drug ... See all stories on this topic » | ||
Stocks With New Trends Developing: AP Pharma, Inc. (OTCBB:APPA), Venaxis ... NIS New York, NY – (NISMAGAZINE) –07/26/2013- A.P. Pharma, Inc. (OTCBB:APPA) closed unchanged at $0.470 after trading 1.64 million shares. It is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based ... See all stories on this topic » | ||
Sizzling Penny Stocks - A.P. Pharma, Inc., WMI HOLDINGS, Cellceutix Corp ... SBWire (press release) A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment